| 发明名称 |
The effective and efficient control of serum phosphate for optimal bone formation |
| 摘要 |
The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity. |
| 申请公布号 |
AU2015275128(A1) |
申请公布日期 |
2016.12.08 |
| 申请号 |
AU20150275128 |
申请日期 |
2015.05.29 |
| 申请人 |
Kyowa Hakko Kirin Co., Ltd.;Ultragenyx Pharmaceutical Inc. |
发明人 |
Kakkis, Emil;San Martin, Javier;Sudo, Tomohiro |
| 分类号 |
C07K14/50;A61K39/395 |
主分类号 |
C07K14/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
